Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Utah tunes up $1m seed fund

The capital will help turn early-stage university ideas into successful spinouts, having already backed a Car T-based immuno-oncological therapy for multiple myeloma.


May 14, 2018

Parkwalk drills further into Salunda

Salunda has raised an undisclosed sum from the University of Oxford Innovation Fund IV and the Parkwalk Opportunities Fund, both managed by Parkwalk Advisors.

May 11, 2018

Axiom abides by $7.6m series A

Axiom Energy, backed by the Stanford-StartX Fund, has received series A capital from a consortium including corporates Great Plains Energy and Shell.

May 11, 2018

Stanford-StartX sues MedWhat

The Stanford-StartX has filed a lawsuit against its portfolio company MedWhat in California.

May 11, 2018

Canon pictures BriefCam acquisition

BriefCam, a spinout from Hebrew University, has agreed to be acquired by Canon for an undisclosed amount, providing an exit to investors including Motorola.

May 11, 2018

TAU Ventures accepts Xcelerator mission

Less than a month after being launched itself, TAU Ventures has joined forces with the Israel Security Authority to establish an accelerator program dubbed Xcelerator.

May 11, 2018

OncoSynergy makes series A headway

The UCSF oncological therapeutics spinout will move from California to Connecticut following a leading investment from state-owned Connecticut Innovations.

May 11, 2018

Robert Gordon registers startup accelerator

RGU expects its University Entrepreneurship Accelerator to back at least 25 projects each year in areas such as healthcare, digital and social enterprise.

May 11, 2018

Lyncean sources $13.8m

Lyncean, based on research at Stanford University and its SLAC National Accelerator Laboratory, has raised $13.8m in a first close of its series B round from backers such as Intel.

May 10, 2018

Fictiv spins $15m narrative

Stanford-StartX Fund has contributed to a $15m series B round for Fictiv, which also attracted commitments from Intel Capital and Bill Gates.

May 10, 2018

Escient ascends with $40m series A

Based on research at Johns Hopkins University, Escient Pharmaceuticals is developing treatments for serious but unserved medical needs.

May 10, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here